arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

Medtronic plc

MDT
$87.19 ▲ +1.27 (+1.48%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
51 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Bullish
auto_awesome

Analytical Summary

Medtronic plc shows strong fundamentals with top-quartile Profit Margin (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth 9.9%
Op. Margin 19.1%
ROIC 2.6%
FCF / Share None
Trailing P/E 89.0x
Price / Book 2.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$9.81B
↑ +9.9%
Net Income Profit after all expenses
$1.24B
↑ +17.8%
Operating Margin Operating profit as % of sales
19.1%
↑ +17.6% 83th
FCF / Share Free cash flow per share
$1.79
↑ +403.0%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
77
Returns
60
Financial Health
77
Cash Quality
64

Dividend History

Dividend / share · sourced from SEC filings
$2.84 Latest / share
+1.4% YoY
+8.0% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 51 quarters